Back to top
more

Smith & Nephew SNATS (SNN)

(Real Time Quote from BATS)

$25.13 USD

25.13
365,171

-0.09 (-0.36%)

Updated May 13, 2024 01:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic

Sriparna Ghosal headshot

Coronavirus Ups the Game for Robotic Surgery: 3 Stocks on Radar

by Sriparna Ghosal

Let's keep a watch on the potentially strong three MedTech stocks, namely SYK, ARAY and MDT with respect to robotic-assisted surgery that showed promises during the pandemic.

Smith+Nephew's (SNN) PICO sNPWT Study Outcome Encouraging

by Zacks Equity Research

Smith+Nephew's (SNN) PICO Single Use Negative Pressure Wound Therapy System (sNPWT) considerably reduces surgical site infections complications and provides better patient outcome.

Integra (IART) Sells Unprofitable Arm to Focus on Core Business

by Zacks Equity Research

Integra (IART) does not expect the selloff to have a material impact on its 2020 results.

Integra (IART) to Buy ACell, Expand Regenerative Capability

by Zacks Equity Research

Integra (IART) expects to close the ACell acquisition in the first quarter of 2021, subject to fulfilment of closing conditions.

Is Smith & Nephew (SNN) a Suitable Stock for Value Investors?

by Zacks Equity Research

Let's see if Smith & Nephew plc (SNN) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Trina Mukherjee headshot

Robot-Assisted Surgery Gains Momentum Amid Coronavirus

by Trina Mukherjee

Let's keep a watch on potentially strong three MedTech stocks with respect to robotic-assisted surgery that have shown promise during the pandemic.

Smith+Nephew Unveils Digital Platform to Boost Patient Care

by Zacks Equity Research

With the help of the care management platform, Smith+Nephew (SNN) aims to help clinicians reduce the patient's post-acute recovery time.

Abbott (ABT) Q4 Earnings Match Estimates, Revenues Beat Mark

by Zacks Equity Research

We are upbeat about Abbott's (ABT) strong and consistent EPD and Medical Devices performances, organically.

Smith & Nephew's JOURNEY II UK Knee System Executes Surgeries

by Zacks Equity Research

The JOURNEY II UK development is expected to provide a major impetus to Smith & Nephew's (SNN) Orthopedics segment.

Smith & Nephew's Study Outcomes for REGENETEN Encouraging

by Zacks Equity Research

Smith & Nephew's (SNN) announces positive study outcomes for REGENETEN.

Smith & Nephew's (SNN) STITCH Study Outcome Encouraging

by Zacks Equity Research

This can be considered a major step in Smith & Nephew's (SNN) commitment toward strengthening its Global Sports Medicine and ENT segment.

Smith & Nephew (SNN) Hits a 52-Week High: What's Driving It?

by Zacks Equity Research

Smith & Nephew (SNN) has been gaining from several positive developments of late.

Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio

by Zacks Equity Research

With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.

Smith & Nephew (SNN) Buys Brainlab, Braces Robotic Ecosystem

by Zacks Equity Research

The transaction by Smith & Nephew (SNN), besides the business purchase, comprises certain intangible assets and the orthopaedic Brainlab salesforce.

Titan Medical (TMDI) Shows Promise on Strategic Developments

by Zacks Equity Research

Titan Medical (TMDI) is putting in a good deal of effort to strengthen its position in the multi-billion dollar computer-assisted robotic surgical technologies market.

Here's Why You Should Invest in Smith & Nephew (SNN) Now

by Zacks Equity Research

Smith & Nephew (SNN) has been gaining investor confidence on consistently positive results.

Here's Why You Should Invest in Baxter International Now

by Zacks Equity Research

Baxter (BAX) teams up with bioMerieux to treat acute kidney injury.

The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco

Swarup Gupta headshot

Is Britain Headed for a Soft Brexit? 5 Picks

by Swarup Gupta

Following May's fresh legislative defeat, Britain could exit the EU while retaining access to its common market.

Smith & Nephew (SNN): Moving Average Crossover Alert

by Zacks Equity Research

Smith & Nephew plc (SNN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front

    Orthopedic Device Market Gains Momentum: 3 Stocks in Focus

    by Zacks Equity Research

    The orthopedics market holds immense potential for investors who are keen on the healthcare space for long-term gains.

      Medical Device Industry Outlook - February 2018

      by Zacks Equity Research

      Amid the concerns related to the tax reform, Congress' postponement of the medical device tax for another two years came as a huge relief to industry participants and investors.

        MedTech Tax Resumes in 2018, 3 Stocks to Suffer

        by Zacks Equity Research

        Sectors that are likely to be hampered the most by the re-imposition of the medical device tax are X-ray and MRI machines, surgical instruments and pacemakers.

          Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm

          by Zacks Equity Research

          Smith & Nephew's (SNN) completion of Rotation Medical acquisition appears highly strategic as this will consolidate the company's position in disruptive technologies and advance its overall growth.